IPhO is the organization whose pharmacist members are universally recognized within the pharmaceutical industry as being the most professionally equipped to contribute to the development, commercialization, promotion, and optimal use of medicines.
In September 2022, 72 IPhO student chapters from across the country embarked on a six-month professional journey to create a drug development plan that would bring a theoretical new bladder cancer medicine to market.
Participating teams were asked to cover drug development from many perspectives, including clinical development, medical strategy, regulatory affairs, and marketing. With support from the Bladder Cancer Advocacy Network (BCAN) team, students also incorporated patient advocacy best practices into their submissions—ensuring that the patient voice is always kept top-of-mind throughout the drug development lifecycle.
What was your motivation to pursue the pharmaceutical industry as a career path?
I had many motivations to pursue the pharmaceutical industry and particularly regulatory affairs as a career path. When I was completing my APPE rotations as a pharmacy student, I had a rotation with AbbVie pharmaceuticals in regulatory affairs advertising and promotion. I learned so much from that experience and I saw the continuous growth, in knowledge but also in opportunities for career advancement, which I found appealing. I gravitated towards regulatory affairs because this function attaches you to innovation in new therapies, new mechanisms, new technologies, etc. This made sense to me as a career path, as I was always excited to lead/work on new projects throughout pharmacy school.